Research Operations
Clinical Trials Day: Thanking the Unsung Heroes
On Clinical Trials Day, now more than ever, it’s important to recognize and thank those unsung heroes at the focal point of research: research sites and institutions. Read more:
Restart Your Research
Advarra recognizes clinical research institutions for their extraordinary response to the COVID-19 pandemic. COVID-19 has created unique challenges, forcing clinical and operational staff to navigate an unprecedented research environment. Clinical trials have been impacted by re-prioritization of resources, staff furloughs and reassignments, and new policies and procedures.
Generating Leadership Buy-In for a Clinical Research Business Intelligence Solution
Strategies for convincing leadership to invest in the tools needed to optimize operations and inform strategic decision-making.
Keep in Touch: Tips for Working with a Single IRB for the First Time
Recent regulations and policies have many institutions establishing policies and processes for working with an external sIRB. Read more:
Q&A – Ask Advarra Live: The Real-World Impact of COVID-19 on Research
We have addressed the most popular Q&A topics from our recent webinar on the research impact of COVID-19 in this blog post. Read more:
Empowering Employees Starts with Building a Strong Culture
Everyone wants to be part of a strong work culture, but how does your organization get there? Check out three tips for building a stronger work culture.
Protocol Feasibility to Promote Trial Efficiency
Many studies do not accrue subjects at the site level, which contributes to a significant amount of waste of staff time and monetary resources. Read more:
How Research Informs the COVID-19 Response
Research doesn’t just inform medical treatment; it informs public health and public policy, and it helps explain human behaviors. Read more:
Advarra EDC Validation Packet Overview
The validation subscription provides your organization with the resources to optimize validation of your Advarra EDC instance.
IRB Review of Coronavirus and Other Emerging Infectious Disease Research: Issues to Consider
Advarra IRB experts discuss unique issues that research involving emerging infectious diseases like coronavirus can raise for IRB review. Read more:
Are “Virtual Trials” Mainstream Yet?
Advarra VP of Insitutional Services James Riddle discusses using virtual trial components in traditional study designs. Read more:
Part 11/Annex 11 Independent Audit and Compliance Assessment
Learn how the Advarra Consulting team deployed a proprietary Part 11 / Annex 11 assessment and mock inspection program.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.